Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future. | J Immunother Precis Oncol;6(1): 19-30, 2023 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future.

Srour, Samer A; Akin, Serkan.

Affiliation

Srour SA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Akin S; Department of Medical Oncology, Hacettepe University Cancer Institute, Hacettepe University, Ankara, Turkey.

J Immunother Precis Oncol ; 6(1): 19-30, 2023 Feb.

Article in En | MEDLINE | ID: mdl-36751657

Key words

CAR T-cell; chimeric antigen receptor; immunotherapy; solid tumors

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Immunother Precis Oncol Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Immunother Precis Oncol Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States